Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephanie Nguyen

Showing results (61-70 of 95) with videos related to

Pageof 10
Sort By:
Molecular Genetics & Genomic Medicine|January 12, 2021
Vanishing white matter: Eukaryotic initiation factor 2B model and the impact of missense mutationsInna Slynko, Stephanie Nguyen, Eline M C Hamilton, et al.
British Journal of Haematology|March 15, 2023
A 16-month-long experience of COVID-19 in allogeneic haematopoietic stem cell transplantation recipients: An SFGM-TC multicentre cohort studyAliénor Xhaard, Constance Xhaard, Marie-Therese Rubio, et al.
Haematologica|May 28, 2016
Outcomes of unrelated cord blood transplantation in patients with multiple myeloma: a survey on behalf of Eurocord, the Cord Blood Committee of Cellular Therapy and Immunobiology Working Party, and the Chronic Leukemia Working Party of the EBMTAnnalisa Paviglianiti, Erick Xavier, Annalisa Ruggeri, et al.
Haematologica|March 10, 2022
High tumor burden before blinatumomab has a negative impact on the outcome of adult patients with B-cell precursor acute lymphoblastic leukemia. A real-world study by the GRAALLAurelie Cabannes-Hamy, Eolia Brissot, Thibaut Leguay, et al.
Molecular Cancer Therapeutics|January 18, 2012
Antitumor activity of a novel bispecific antibody that targets the ErbB2/ErbB3 oncogenic unit and inhibits heregulin-induced activation of ErbB3Charlotte F McDonagh, Alexandra Huhalov, Brian D Harms, et al.
Ejhaem|December 18, 2024
Incidence and risk factors of graft failure in allogeneic hematopoietic stem cell transplantation for mucopolysaccharidosis in a nationwide pediatric cohort. A study on behalf of the Francophone Society of Bone Marrow Transplantation and Cellular TherapyLaura Danhardt, Arnaud Wiedemann, Gerard Michel, et al.
Blood Advances|July 16, 2025
Older matched sibling donor versus young haplo-identical donor for elderly patients with acute myeloid leukemiaXavier Poire, Myriam Labopin, Emmanuelle Polge, et al.
Bone Marrow Transplantation|March 22, 2024
Transplantation for myelofibrosis patients in the ruxolitinib era: a registry study from the Société Francophone de Greffe de Moelle et de Thérapie CellulaireSara Villar, Sylvie Chevret, Xavier Poire, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 11, 2015
Outcomes of Cord Blood Transplantation Using Reduced-Intensity Conditioning for Chronic Lymphocytic Leukemia: A Study on Behalf of Eurocord and Cord Blood Committee of Cellular Therapy and Immunobiology Working Party, Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation, and the Societé Française de Greffe de Moelle et Therapie CellulaireErick Xavier, Jérôme Cornillon, Annalisa Ruggeri, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 30, 2021
On Behalf of the SFGM-TC: Retrospective Comparison of Reduced and Higher Intensity Conditioning for High-Risk Myelodysplastic Syndrome Treated With Allogeneic Stem-Cell TransplantationArnaud Campidelli, Marie Robin, Thomas Remen, et al.
Pageof 10

Showing results (61-70 of 95) with videos related to

Sort By:
Pageof 10
Molecular Genetics & Genomic Medicine|January 12, 2021
Vanishing white matter: Eukaryotic initiation factor 2B model and the impact of missense mutationsInna Slynko, Stephanie Nguyen, Eline M C Hamilton, et al.
British Journal of Haematology|March 15, 2023
A 16-month-long experience of COVID-19 in allogeneic haematopoietic stem cell transplantation recipients: An SFGM-TC multicentre cohort studyAliénor Xhaard, Constance Xhaard, Marie-Therese Rubio, et al.
Haematologica|May 28, 2016
Outcomes of unrelated cord blood transplantation in patients with multiple myeloma: a survey on behalf of Eurocord, the Cord Blood Committee of Cellular Therapy and Immunobiology Working Party, and the Chronic Leukemia Working Party of the EBMTAnnalisa Paviglianiti, Erick Xavier, Annalisa Ruggeri, et al.
Haematologica|March 10, 2022
High tumor burden before blinatumomab has a negative impact on the outcome of adult patients with B-cell precursor acute lymphoblastic leukemia. A real-world study by the GRAALLAurelie Cabannes-Hamy, Eolia Brissot, Thibaut Leguay, et al.
Molecular Cancer Therapeutics|January 18, 2012
Antitumor activity of a novel bispecific antibody that targets the ErbB2/ErbB3 oncogenic unit and inhibits heregulin-induced activation of ErbB3Charlotte F McDonagh, Alexandra Huhalov, Brian D Harms, et al.
Ejhaem|December 18, 2024
Incidence and risk factors of graft failure in allogeneic hematopoietic stem cell transplantation for mucopolysaccharidosis in a nationwide pediatric cohort. A study on behalf of the Francophone Society of Bone Marrow Transplantation and Cellular TherapyLaura Danhardt, Arnaud Wiedemann, Gerard Michel, et al.
Blood Advances|July 16, 2025
Older matched sibling donor versus young haplo-identical donor for elderly patients with acute myeloid leukemiaXavier Poire, Myriam Labopin, Emmanuelle Polge, et al.
Bone Marrow Transplantation|March 22, 2024
Transplantation for myelofibrosis patients in the ruxolitinib era: a registry study from the Société Francophone de Greffe de Moelle et de Thérapie CellulaireSara Villar, Sylvie Chevret, Xavier Poire, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 11, 2015
Outcomes of Cord Blood Transplantation Using Reduced-Intensity Conditioning for Chronic Lymphocytic Leukemia: A Study on Behalf of Eurocord and Cord Blood Committee of Cellular Therapy and Immunobiology Working Party, Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation, and the Societé Française de Greffe de Moelle et Therapie CellulaireErick Xavier, Jérôme Cornillon, Annalisa Ruggeri, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 30, 2021
On Behalf of the SFGM-TC: Retrospective Comparison of Reduced and Higher Intensity Conditioning for High-Risk Myelodysplastic Syndrome Treated With Allogeneic Stem-Cell TransplantationArnaud Campidelli, Marie Robin, Thomas Remen, et al.
Pageof 10